AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in Percent.
The item "Debt-To-Capital-Ratio" stands at 40.54 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of AstraZeneca PLC's third quarter, the item "Debt To Capital Ratio" stands at 40.54 Percent. This represents a decrease of -0.84 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.25 percentage points compared to the value the year prior.
The 1 year change in percentage points is -2.25.
The 3 year change in percentage points is -4.36.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Debt To Capital Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Debt To Capital Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Debt To Capital Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Debt To Capital Ratio | 317,433,206,677.55 |
![]() | Novartis AG - Debt To Capital Ratio | 255,096,620,580.91 |